| AA | Ascorbic acid |
| ALL | Acute myeloid leukemia |
| AML | Acute myeloid leukemia |
| CLL | Chronic lymphocytic leukemia |
| CR | Complete remission |
| CoQ10 | Coenzyme Q10 |
| EGCG | Epigallocatechin 3 gallate |
| GM | Gut microbiota |
| GVHD | Graft-versus-host disease |
| HIF1α | Hypoxia-inducible factor 1α |
| HSCT | Hematopoietic stem cell transplantation |
| IGF1 | Insulin-like growth factor 1 |
| IkB | NkB inhibitor |
| LFS | Leukemia-free survival |
| LSC | Leukemia stem cells |
| MAMs | Macrophages associated with myeloma |
| MMP-2 | Matrix metalloproteinase-2 |
| MMP-9 | Matrix metalloproteinase-9 |
| MDS | Myelodysplastic syndromes |
| MC | Monoclonal component |
| MGUS | Monoclonal gammopathies of uncertain significance |
| MM | Multiple myeloma |
| NFκB | Nuclear factor kappa B |
| ORR | Overall response rate |
| OS | Overall survival |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| TTT | Time to treatment |
| VEGF | Vascular endothelium growth factor |
| VDR | Vitamin D receptor |